Chemoinformaics analysis of Kaempferol 3-rhamnosyldiglucoside
| Molecular Weight | 756.663 | nRot | 9 |
| Heavy Atom Molecular Weight | 716.343 | nRig | 36 |
| Exact Molecular Weight | 756.211 | nRing | 6 |
| Solubility: LogS | -2.411 | nHRing | 4 |
| Solubility: LogP | -1.659 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 93 | No. of Aliphatic Hetero Cycles | 3 |
| No. of Heavy Atom | 53 | No. of Aromatic Carbocycles | 2 |
| nHetero | 20 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 40 | No. of Saturated Hetero Cycles | 3 |
| No. of Carbon atom | 33 | No. of Saturated Rings | 3 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 20 | No. of Arom Bond | 17 |
| nHA | 20 | APOL | 97.8217 |
| nHD | 12 | BPOL | 53.1483 |
| QED | 0.1 |
| Synth | 5.321 |
| Natural Product Likeliness | 1.671 |
| NR-PPAR-gamma | 0.891 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.98 |
| HIA | 0.986 |
| CACO-2 | -6.42 |
| MDCK | 0.000169316 |
| BBB | 0.347 |
| PPB | 0.763462 |
| VDSS | 0.504 |
| FU | 0.309185 |
| CYP1A2-inh | 0.001 |
| CYP1A2-sub | 0.009 |
| CYP2c19-inh | 0.005 |
| CYP2c19-sub | 0.05 |
| CYP2c9-inh | 0 |
| CYP2c9-sub | 0.236 |
| CYP2d6-inh | 0.001 |
| CYP2d6-sub | 0.119 |
| CYP3a4-inh | 0.006 |
| CYP3a4-sub | 0.002 |
| CL | 1.042 |
| T12 | 0.348 |
| hERG | 0.014 |
| Ames | 0.467 |
| ROA | 0.056 |
| SkinSen | 0.006 |
| Carcinogencity | 0.068 |
| EI | 0.004 |
| Respiratory | 0.005 |
| NR-Aromatase | 0.952 |
| Antiviral | Yes |
| Prediction | 0.795303 |